ANDA 74540, held by ANI Pharmaceuticals. Nicardipine Hydrochloride.
As of Nov 22, 2026, ANDA 74540 (Nicardipine Hydrochloride), held by ANI Pharmaceuticals, was first approved by FDA on Oct 28, 1996, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 28, 1996 | Original application | Approved | None posted |
| Nicardipine Hydrochloride20MG · capsule;oral | Nicardipine Hydrochloride | Discontinued |
| Nicardipine Hydrochloride30MG · capsule;oral | Nicardipine Hydrochloride | Discontinued |
| Nov 5, 2001 | Supplement 11Labeling | Approved | None posted |
| Aug 30, 2001 | Supplement 10Manufacturing | Approved | None posted |
| Jul 7, 2000 | Supplement 8Manufacturing | Approved | None posted |
| Feb 25, 2000 | Supplement 9Labeling | Approved | None posted |
| Oct 29, 1999 | Supplement 6Manufacturing | Approved | None posted |
| Oct 29, 1999 | Supplement 7Manufacturing | Approved | None posted |
| Mar 9, 1998 | Supplement 4Manufacturing | Approved | None posted |
| Jul 11, 1997 | Supplement 1Manufacturing | Approved | None posted |
| Jul 11, 1997 | Supplement 2Manufacturing | Approved | None posted |
| Jul 11, 1997 | Supplement 3Manufacturing | Approved | None posted |
| Oct 28, 1996 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters